Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles R M, Cabero L
Unitat de Medicina Materno-fetal, Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain.
Am J Perinatol. 1998 Feb;15(2):81-5. doi: 10.1055/s-2007-993903.
The objective of this article is to evaluate the plasma levels of coagulation and fibrinolysis parameters in the third trimester of gestation and 72 hr postdelivery. Antithrombin III (ATIII), thrombin-antithrombin III complexes (TAT), heparin cofactor II (HCII), protein C (PC), protein S (PS), tissue plasminogen activator (t-PA), D-dimer, and plasminogen activator inhibitors (PAI-1 and PAI-2) levels in uncomplicated pregnancies and in pregnancies complicated by intrauterine growth retardation (IUGR) have been determined. Normal pregnant women (n = 63) and women whose was complicated by IUGR (n = 10) formed the study population. Coagulation and fibrinolysis parameters were estimated using commercial tests. There were no differences in ATIII, HCII, and PS levels between normal and IUGR pregnancies. TAT, t-PA, and D-dimer levels were higher in IUGR pregnancy than in the uncomplicated pregnancy group. PAI-1 and PAI-2 were found depressed in IUGR pregnancy when compared with normal pregnancy. Changes in coagulation and fibrinolytic systems occur in plasma of women with pregnancies complicated by IUGR. The results suggest an activation of the coagulation system in pregnancies complicated by IUGR. Reduced PAI-2 and high TAT levels correlate with birth weight. In IUGR pregnancies a hypercoagulative state with hyperfibrinolytic compensatory mechanisms is suggested.
本文的目的是评估妊娠晚期及产后72小时血浆中凝血和纤溶参数水平。已测定了正常妊娠及合并宫内生长受限(IUGR)妊娠中抗凝血酶III(ATIII)、凝血酶 - 抗凝血酶III复合物(TAT)、肝素辅因子II(HCII)、蛋白C(PC)、蛋白S(PS)、组织纤溶酶原激活物(t - PA)、D - 二聚体以及纤溶酶原激活物抑制剂(PAI - 1和PAI - 2)的水平。研究人群包括正常孕妇(n = 63)和合并IUGR的孕妇(n = 10)。使用商业检测方法评估凝血和纤溶参数。正常妊娠和IUGR妊娠之间的ATIII、HCII和PS水平没有差异。IUGR妊娠中的TAT、t - PA和D - 二聚体水平高于正常妊娠组。与正常妊娠相比,IUGR妊娠中的PAI - 1和PAI - 2水平降低。合并IUGR妊娠的女性血浆中凝血和纤溶系统发生变化。结果表明合并IUGR的妊娠中凝血系统被激活。PAI - 2降低和TAT水平升高与出生体重相关。在IUGR妊娠中提示存在高凝状态伴高纤溶代偿机制。